Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Company announces first cGMP manufacturing facility for commercial use in Suzhou, China
Successful LCM planning commences early in the lifecycle of a drug, reports GBI Research
In the second half of a two-part article, Andreas Nixdorf, SGS Life Science Services, discusses the practical aspects of extractables and leachables testing for containers, closures and other packaging
Growing customer demand drives expansion in the American Midwest
To further accelerate growth outside the US
The pharmaceutical industry has recently been reported as facing a reproducibility crisis where researchers have failed to reproduce key drug research results. Roumen Bogoev, Bio-Rad Laboratories looks at how this issue can be improved for western blotting techniques
For the development of a treatment for prostate cancer
Sterile product filter manufacturers will usually supply a validation guide. However, different fluids can influence the extractables and filtration efficacy compared with standardised tests. Mozamal Nazir, Senior Scientist, Porvair Filtration, explains the need for a simulated filtration process
To produce APIs for oral semaglutide plus other insulin products and handle tableting and packaging
To ensure proper delivery, inhalation products require APIs and carriers to be sized precisely and mixed carefully. Hosokawa Micron reviews the mixing and size reduction technologies available
The facility will be the operations and warehousing hub for customers in Europe
Patient safety demands strict quality controls for drug manufacturers, but increasing drug shortages have led to new initiatives by the regulatory authorities that aim to streamline the oversight of new drugs, production processes and facility inspections